Canopy Partners, LLC Dr Reddys Laboratories LTD Transaction History
Canopy Partners, LLC
- $262 Billion
- Q4 2024
A detailed history of Canopy Partners, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Canopy Partners, LLC holds 19,301 shares of RDY stock, worth $270,020. This represents 0.12% of its overall portfolio holdings.
Number of Shares
19,301
Previous 3,785
409.93%
Holding current value
$270,020
Previous $301 Million
1.35%
% of portfolio
0.12%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding RDY
# of Institutions
261Shares Held
75.8MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$160 Million0.35% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$132 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$78.5 Million36.88% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.36MShares$75 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$68.5 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.32B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...